On August 9, 2024, the fifth “Angel of Life for Africa” midwifery training program was successfully completed after two weeks of training at Wenzhou Medical University in east China’s Zhejiang Province. The trainin...
The ANGEL-ACT registry was supported by the National Key Research and Development Program of China,grant number 2016YFC1301500.
Objectives To identify the occurrence rate and predictors of futile recanalisation after endovascular therapy(EVT)for acute vertebrobasilar artery occlusion(VBAO).Methods Participants of the Endovascular Treatment Key...
funded by the Beijing Natural Science Foundation(No.220016);National Natural Science Foundation of China(No.62272325);National Key R&D Program(No.2018AAA0102600);Beijing Municipal Administration of Hospitals Incubating Program(No.PX2023022),Shanghai HeartCare Medical Technology,HeMo(China)Bioengineering and Sino Medical Sciences Technology.
Rationale Unsuccessful thrombectomy of acute large vessel occlusions(LVOs)has been associated with unfavourable outcomes.Multiple randomised controlled trials(RCTs)have reported a failure rate of 12%–41%for thrombect...
The inability of traditional privacy-preserving models to protect multiple datasets based on sensitive attributes has prompted researchers to propose models such as SLOMS,SLAMSA,(p,k)-Angelization,and(p,l)-Angelizatio...
I am very pleased and privileged to be addressing the thematic segment of the Third Belt and Road Forum for the second time.I am also delighted to be back to Beijing in less than 3 months.My latest visit was in last J...
funded by the National Key Research and Development Program of China(grant number 2016YFC1301500).
Background and purpose An analysis of the ASTER 2 trial revealed similar final recanalisation levels and clinical outcomes in acute large vessel occlusion(LVO)stroke between stent retrieval(SR)alone as a first-line me...